Do you want to read an article? Please log in or register.
A 52-Week Prophylactic Randomised Control Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder
Further Publications Psychiatry
Related content
Aging and Cognitive FunctionsAlzheimer’s DiseaseDementia
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
Lancet Neurol.
Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, Bories L, Cufi MN, Dantoine T, Dartigues JF, Desclaux F, Gabelle A, Gasnier Y, Pesce A, Sudres K, Touchon J, Robert P, Rouaud O, Legrand P, Payoux P, Caubere JP, Weiner M, Carrié I, Ousset PJ, Vellas B; MAPT Study Group
doi: 10.1016/
RECOMMENDED
Anxiety and Depression
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder
Psychother Psychosom.
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP
doi: 10.1159/000502652.
Bipolar Disorder
Fish Oil Supplementation Alters Emotion-Generated Corticolimbic Functional Connectivity in Depressed Adolescents at High-Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled fMRI Trial
Bipolar Disord
McNamara RK, Li W, Lei D, Tallman MJ, Welge JA, Strawn JR, Patino LR, DelBello MP
doi: 10.1111/bdi.13110
Bipolar Disorder
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial
Lancet Psychiatry.
Husain MI, Chaudhry IB, Khoso AB, Husain MO, Hodsoll J, Ansari MA, Naqvi HA, Minhas FA, Carvalho AF, Meyer JH, Deakin B, Mulsant BH, Husain N, Young AH
doi: 10.1016/S2215-0366(20)30138-3.
Aging and Cognitive FunctionsAnxiety and Depression
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial
J Clin Psychopharmacol.
Mazereeuw G, Herrmann N, Oh PI, Ma DW, Wang CT, Kiss A,
Lanctôt KL
doi: 10.1097/
Psychosis and Schizophrenia
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis
Biol Psychiatry.
Amminger GP, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD
doi: 10.1016/j.biopsych.2019.08.030.
Bipolar DisorderAlcohol Use Disorder (AUD)
Feasibility and acceptability of integrated psychological therapy versus treatment as usual for people with bipolar disorder and co-morbid alcohol use: A single blind randomised controlled trial
J Affect Disord.
Jones SH, Riste L, Robinson H, Holland F, Peters S, Hartwell R, Berry K, Fitzsimmons M, Wilson I, Hilton C, Long R, Bateman L, Weymouth E, Owen R, Roberts C, Barrowclough C
doi: 10.1016/j.jad.
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Lancet.
CRASH-3 trial collaborators.
doi: 10.1016/S0140-6736(19)32233-0.
COMMENTED
Aging and Cognitive Functions
Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial
★ 3
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
JAMA
Bischoff-Ferrari HA, Vellas B, Rizzoli R, Kressig RW, da Silva JAP, Blauth M, Felson DT, McCloskey EV, Watzl B, Hofbauer LC, Felsenberg D, Willett WC, Dawson-Hughes B, Manson JE, Siebert U, Theiler R, Staehelin HB, de Godoi Rezende Costa Molino C, Chocano-Bedoya PO, Abderhalden LA, Egli A, Kanis JA, Orav EJ, DO-HEALTH Research Group.
doi: 10.1001/jama.2020.16909